Veloxis Pharmaceuticals A/S (VELOX.CO) News|
United States

Veloxis Pharmaceuticals A/S (VELOX.CO)

VELOX.CO on Copenhagen Stock Exchange

27 Jun 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, Jun 13 2016

BRIEF-Veloxis Pharmaceuticals raises DKK 4.1 mln from exercise of warrants

* Capital increase from exercise of warrants amounts to 4.1 million Danish crowns ($620,977)

BRIEF-Veloxis Pharmaceuticals Q1 operating loss at $6.9 mln

* Said on Wednesday Q1 revenue $1.5 million versus $647,000 year ago

BRIEF-Veloxis Pharmaceuticals appoints Michael Thomas Heffernan new chairman

* Board of directors constituted itself with Michael Thomas Heffernan as chairman of board

BRIEF-Veloxis Pharmaceuticals: Johnny Stilou to step down as EVP & CFO

* Johnny Stilou will step down as EVP & Chief Financial Officer as part of the Company's decision to close down all Danish activities and move to the US

BRIEF-Veloxis FY operating loss widens to DKK 197.1 million

* FY revenue 14.2 million Danish crowns ($2.1 million) versus 123.4 million crowns year ago

BRIEF-Veloxis Pharmaceuticals moves Danish activities to the U.S.

* Veloxis Pharmaceuticals has decided to close its office in Hørsholm, Denmark, and move all activities to the U.S. where most of the company's current activities is already located

Select another date: